UA97663C2 - Применение bifidobacterium lactis cncm i-3446 для улучшения кишечной микробиоты у детей, родившихся путем кесарева сечения - Google Patents

Применение bifidobacterium lactis cncm i-3446 для улучшения кишечной микробиоты у детей, родившихся путем кесарева сечения

Info

Publication number
UA97663C2
UA97663C2 UAA200910897A UAA200910897A UA97663C2 UA 97663 C2 UA97663 C2 UA 97663C2 UA A200910897 A UAA200910897 A UA A200910897A UA A200910897 A UAA200910897 A UA A200910897A UA 97663 C2 UA97663 C2 UA 97663C2
Authority
UA
Ukraine
Prior art keywords
promoting
development
bifidobacterium lactis
intestinal microbiota
caesarean section
Prior art date
Application number
UAA200910897A
Other languages
English (en)
Ukrainian (uk)
Inventor
Карл-Йозеф Хубер-Хааг
Мари-Клер Фишот
Флоренс Рошат
Норберт Спренгер
Original Assignee
Нестек С.А.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Нестек С.А. filed Critical Нестек С.А.
Publication of UA97663C2 publication Critical patent/UA97663C2/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/11—Lactobacillus
    • A23V2400/175—Rhamnosus
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/51—Bifidobacterium
    • A23V2400/531—Lactis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nutrition Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Pediatric Medicine (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

Применение Bifidobacterium lactis CNCM I-3446 в производстве лекарственного средства или лекарственной пищевой композиции в качестве стимулятора развития начальной бифидогенной кишечной микробиоты или в качестве средства для снижения риска дальнейшего развития аллергии, или в качестве средства для предупреждения или лечения диареи у детей, родившихся путем кесарева сечения. Дополнительно может содержать смесь олигосахаридов.
UAA200910897A 2007-03-28 2008-03-27 Применение bifidobacterium lactis cncm i-3446 для улучшения кишечной микробиоты у детей, родившихся путем кесарева сечения UA97663C2 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP07105074A EP1974743A1 (en) 2007-03-28 2007-03-28 Probiotics to Improve Gut Microbiota
PCT/EP2008/053611 WO2008116892A1 (en) 2007-03-28 2008-03-27 Probiotics to improve gut microbiota

Publications (1)

Publication Number Publication Date
UA97663C2 true UA97663C2 (ru) 2012-03-12

Family

ID=38051788

Family Applications (2)

Application Number Title Priority Date Filing Date
UAA200910897A UA97663C2 (ru) 2007-03-28 2008-03-27 Применение bifidobacterium lactis cncm i-3446 для улучшения кишечной микробиоты у детей, родившихся путем кесарева сечения
UAA200910896A UA97662C2 (ru) 2007-03-28 2008-03-27 Применение синбиотика для улучшения кишечной микробиоты у детей, родившихся путем кесаревого сечения

Family Applications After (1)

Application Number Title Priority Date Filing Date
UAA200910896A UA97662C2 (ru) 2007-03-28 2008-03-27 Применение синбиотика для улучшения кишечной микробиоты у детей, родившихся путем кесаревого сечения

Country Status (15)

Country Link
US (4) US20100119497A1 (ru)
EP (6) EP1974743A1 (ru)
CN (4) CN101646453A (ru)
AU (4) AU2008231702B2 (ru)
BR (4) BRPI0809626A2 (ru)
CA (4) CA2682654A1 (ru)
ES (2) ES2434566T3 (ru)
MX (4) MX337667B (ru)
MY (1) MY151137A (ru)
PL (2) PL2131680T3 (ru)
PT (2) PT2131680E (ru)
RU (4) RU2009139667A (ru)
UA (2) UA97663C2 (ru)
WO (4) WO2008116892A1 (ru)
ZA (3) ZA200907541B (ru)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPQ899700A0 (en) 2000-07-25 2000-08-17 Borody, Thomas Julius Probiotic recolonisation therapy
BRPI0708689A2 (pt) 2006-03-07 2011-06-07 Nestec Sa mistura simbiótica
RU2445361C2 (ru) * 2006-06-13 2012-03-20 Нестек С.А. Профилактика и лечение воспаления среднего уха с помощью непатогенных штаммов бактерий
EP2147678A1 (en) * 2008-07-21 2010-01-27 Nestec S.A. Probiotics to increase IgA secretion in infants born by caesarean section
US8498729B2 (en) 2008-08-29 2013-07-30 Smp Logic Systems Llc Manufacturing execution system for use in manufacturing baby formula
WO2010063601A1 (en) * 2008-12-05 2010-06-10 Nestec S.A. Compositions for use in low-birth weight infants
EP2206506A1 (en) * 2008-12-18 2010-07-14 Bracco Imaging S.p.A Probiotic formulations
WO2010103132A1 (es) * 2009-03-10 2010-09-16 Hero España, S.A. Aislamiento, identificación y caracterización de cepas con actividad probiótica a partir de heces de lactantes alimentados exclusivamente con leche materna
CA2767960A1 (en) * 2009-07-31 2011-02-03 Nestec S.A. Nutritional composition for breast-fed infants or pets with probiotics and selected nutrients
EP2289527B1 (en) 2009-08-25 2018-02-21 Nestec S.A. Bifidobacterium longum and functional GI disorders
WO2011151941A1 (ja) 2010-06-04 2011-12-08 国立大学法人東京大学 制御性ｔ細胞の増殖または集積を誘導する作用を有する組成物
EP2452575A1 (en) * 2010-11-15 2012-05-16 Nestec S.A. Array of age-tailored nutritional formula with probiotics
EP2465507A1 (en) * 2010-11-23 2012-06-20 Nestec S.A. Oligosaccharide composition for treating skin diseases
EP2455387A1 (en) 2010-11-23 2012-05-23 Nestec S.A. Oligosaccharide mixture and food product comprising this mixture, especially infant formula
EP2658559A1 (en) * 2010-12-29 2013-11-06 Nestec S.A. Fiber and probiotics for reducing intestinal symptoms related to stress
EE05721B1 (et) 2011-02-25 2014-08-15 OÜ Tervisliku Piima Biotehnoloogiate Arenduskeskus Isoleeritud mikroorganismi tüvi L. plantarum MCC1 DSM 23881 ja selle kasutamine
EP2510932A1 (en) * 2011-04-15 2012-10-17 Nestec S.A. Lactobacillus paracasei NCC2461 (ST11) for use by perinatal maternal administration in the reduction and prevention of allergies in progeny
JP2014516589A (ja) 2011-06-20 2014-07-17 エイチ．ジェイ．ハインツ カンパニー プロバイオティック組成物及び方法（ｐｒｏｂｉｏｔｉｃｃｏｍｐｏｓｉｔｉｏｎａｎｄｍｅｔｈｏｄｓ）
JP5877902B2 (ja) 2011-08-17 2016-03-08 マイクロバイオーム セラピューティクス，エルエルシー バクテロイデス門の胃腸管微生物相対フィルミクテス門の微生物相の比を上昇させるための組成物および製剤の使用
ES2546262T5 (es) * 2011-10-18 2019-04-12 Nestec Sa Composición para emplear en la promoción de la absorción del magnesio y/o la retención del magnesio
CA2892588A1 (en) 2011-12-01 2013-06-06 School Corporation, Azabu Veterinary Medicine Educational Institution Human-derived bacteria that induce proliferation or accumulation of regulatory t cells
JP6115094B2 (ja) * 2012-11-15 2017-04-19 株式会社Ｇｓユアサ 蓄電素子及び蓄電素子の製造方法
BR112015028164B1 (pt) 2013-05-10 2022-02-08 H.J. Heinz Company Brands Llc Usos da bactéria probiótica, lactobacillus paracasei, para tratar uma infecção microbiana e para prevenir ou reduzir a gravidade de uma infecção microbiana
US11135232B2 (en) 2013-11-15 2021-10-05 Societe Des Produits Nestle S.A. Compositions for use in the prevention or treatment of necrotizing enterocolitis in infants and young children
MX2016006220A (es) 2013-11-15 2016-08-08 Nestec Sa Composiciones para usar en la prevencion o tratamiento de la enterocolitis necrotizante en infantes y niños pequeños nacidos por cesarea.
US10758555B2 (en) 2013-11-15 2020-09-01 Societe Des Produits Nestle S.A. Compositions for preventing or treating allergies in infants from or fed by non secretor mothers by providing fucosylated-oligosaccharides in particular among infants at risk or born by C-section
MX2016006060A (es) * 2013-11-15 2016-08-03 Nestec Sa Composiciones para usar en la prevencion o tratamiento de la enterocolitis necrotizante en infantes y niños pequeños.
KR20170072879A (ko) 2014-10-29 2017-06-27 네스텍 소시에테아노님 생애 초기에 미생물총 불균형을 회복하기 위한 l. 루테리의 용도
EP3294308A4 (en) 2015-05-14 2019-03-06 University of Puerto Rico PROCESS FOR RECOVERING THE BIOZOOSE OF NEWBORN
AU2016303003A1 (en) * 2015-08-04 2017-12-07 Société des Produits Nestlé S.A. Nutritional compositions and infant formulas comprising Bifidobacterium animalis ssp. lactis and optionally a mix of oligosaccharides for inducing a gut microbiota close to the one of breast fed infants
WO2017043963A1 (en) * 2015-09-11 2017-03-16 N.V. Nutricia Kit of parts for stimulating microbiota health after non-natural birth
US11564667B2 (en) 2015-12-28 2023-01-31 New York University Device and method of restoring microbiota of newborns
US11229659B2 (en) 2016-01-26 2022-01-25 Societe Des Produits Nestle S.A. Compositions with specific oligosaccharides to prevent or treat allergies
EP3466435B1 (en) * 2016-05-31 2023-08-16 Morinaga Milk Industry Co., Ltd. Brain function improving agent
US20180030403A1 (en) 2016-07-28 2018-02-01 Bobban Subhadra Devices, systems and methods for the production of humanized gut commensal microbiota
EP3493686B1 (en) * 2016-08-04 2024-03-27 Société des Produits Nestlé S.A. Nutritional compositions and infant formulas comprising a mix of oligosaccharides and optionally bifidobacterium lactis for preventing, treating or reducing the severity of non-rotavirus-associated diarrhoea
MX2019013143A (es) * 2017-05-05 2020-07-14 Nestle Sa Tratamiento de colicos infantiles.
EP3661371A1 (en) * 2017-08-04 2020-06-10 Société des Produits Nestlé S.A. Probiotic bacteria preconditioned in a gos-containing medium and use thereof
CN113164532A (zh) * 2018-05-30 2021-07-23 进化生物***股份有限公司 H5功能性长双歧杆菌婴儿亚种的组合物和使用方法
CN108935698A (zh) * 2018-09-11 2018-12-07 内蒙古伊利实业集团股份有限公司 一种预防小儿腹泻疾病的营养组合物及应用
CN109497271A (zh) * 2018-12-06 2019-03-22 江苏奥迈生物科技有限公司 一种提高断奶仔猪免疫力的复合饲料添加剂及其制备方法
WO2020251249A1 (ko) * 2019-06-11 2020-12-17 주식회사 천랩 영유아의 장내 미생물 불균형도를 탐지하는 방법
TWI754302B (zh) * 2019-06-21 2022-02-01 大江生醫股份有限公司 乳雙歧桿菌tci604及其代謝產物的應用
CN111053244A (zh) * 2019-12-06 2020-04-24 山东体育学院 一种基于肠道微生物的营养调节方法及***
CN111296711A (zh) * 2020-03-31 2020-06-19 广州纽缤乐营养科技股份有限公司 一种益生菌固体饮料及其制备方法
WO2023237679A1 (en) * 2022-06-10 2023-12-14 Dsm Ip Assets B.V. Combinations comprising vitamin b2 and lactobacillus rhamnosus
WO2023237687A1 (en) * 2022-06-10 2023-12-14 Dsm Ip Assets B.V. Combinations comprising vitamin b2 and lactobacillus rhamnosus
WO2024105265A1 (fr) 2022-11-17 2024-05-23 Institut National de Recherche pour l’Agriculture, l’Alimentation et l’Environnement Limosilactobacillus mucosae et désordres nécessitant un accroissement du niveau de glp-1

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4839281A (en) 1985-04-17 1989-06-13 New England Medical Center Hospitals, Inc. Lactobacillus strains and methods of selection
SU1743607A1 (ru) * 1990-02-05 1992-06-30 2-й Московский государственный медицинский институт им.Н.И.Пирогова Способ профилактики дисбактериоза кишечника у новорожденных детей
EP0577903B1 (fr) 1992-07-06 1997-12-17 Societe Des Produits Nestle S.A. Agent antigastrite
DK0768375T4 (da) * 1992-07-06 2002-09-16 Nestle Sa Mælkesyrebakterier
FI104465B (fi) 1995-06-14 2000-02-15 Valio Oy Proteiinihydrolysaatteja allergioiden hoitamiseksi tai estämiseksi, niiden valmistus ja käyttö
NL1010770C2 (nl) * 1998-12-09 2000-06-13 Nutricia Nv Preparaat dat oligosacchariden en probiotica bevat.
EP1034787A1 (en) 1999-03-11 2000-09-13 Société des Produits Nestlé S.A. Lactobacillus strains preventing diarrhea caused by pathogenic bacteria
DE19958985A1 (de) * 1999-12-07 2001-06-13 Nutricia Nv Oligosaccharidmischung
FI110668B (fi) * 2000-06-20 2003-03-14 Aboatech Ab Oy Probioottien käyttö atooppisten sairauksien primaariseen ehkäisyyn
WO2005000748A1 (en) 2003-06-27 2005-01-06 Bio-Circuit Aps A biogas producing facility with anaerobic hydrolysis
MX2007012697A (es) * 2005-04-13 2008-01-14 Nestec Sa Formula para infantes con probioticos.
EP1776877A1 (en) * 2005-10-21 2007-04-25 N.V. Nutricia Method for stimulating the intestinal flora
PL1988786T3 (pl) * 2006-02-10 2010-10-29 Nestec Sa Mieszanka oligosacharydowa
BRPI0708689A2 (pt) * 2006-03-07 2011-06-07 Nestec Sa mistura simbiótica
RU2445361C2 (ru) * 2006-06-13 2012-03-20 Нестек С.А. Профилактика и лечение воспаления среднего уха с помощью непатогенных штаммов бактерий

Also Published As

Publication number Publication date
WO2008116907A1 (en) 2008-10-02
CA2680093A1 (en) 2008-10-02
WO2008116904A1 (en) 2008-10-02
WO2008116892A1 (en) 2008-10-02
US20100150874A1 (en) 2010-06-17
AU2008231763A1 (en) 2008-10-02
EP2131859B1 (en) 2016-04-27
EP2131859A1 (en) 2009-12-16
BRPI0809626A2 (pt) 2014-09-23
ES2434566T3 (es) 2013-12-16
MY151137A (en) 2014-04-30
RU2009139658A (ru) 2011-05-10
AU2008231775A1 (en) 2008-10-02
EP2129393A1 (en) 2009-12-09
PL2131680T3 (pl) 2014-01-31
EP2131680A1 (en) 2009-12-16
MX337667B (es) 2016-03-14
CN101646453A (zh) 2010-02-10
EP2489280A3 (en) 2013-06-26
CA2679081A1 (en) 2008-10-02
ZA200907538B (en) 2011-04-28
RU2009139667A (ru) 2011-05-10
US20100086527A1 (en) 2010-04-08
RU2009139669A (ru) 2011-05-10
CN101652080A (zh) 2010-02-17
MX2009009442A (es) 2009-09-14
EP2131680B1 (en) 2013-08-14
MX2009009318A (es) 2009-09-10
BRPI0809355A2 (pt) 2014-09-02
RU2521500C2 (ru) 2014-06-27
US20100119497A1 (en) 2010-05-13
CN101646452A (zh) 2010-02-10
RU2456008C2 (ru) 2012-07-20
UA97662C2 (ru) 2012-03-12
AU2008231702B2 (en) 2014-01-16
CN101652079A (zh) 2010-02-17
PT2131859T (pt) 2016-07-13
BRPI0809622A2 (pt) 2014-09-16
EP2489280A2 (en) 2012-08-22
CA2682654A1 (en) 2008-10-02
AU2008231778A1 (en) 2008-10-02
AU2008231763B2 (en) 2013-10-31
AU2008231702A1 (en) 2008-10-02
BRPI0809356A2 (pt) 2014-09-02
CA2678994A1 (en) 2008-03-27
ZA200907541B (en) 2011-04-28
MX2009009931A (es) 2009-09-24
ZA200907731B (en) 2011-04-28
MX2009010252A (es) 2009-10-13
ES2577434T3 (es) 2016-07-14
PT2131680E (pt) 2013-10-28
WO2008116916A1 (en) 2008-10-02
EP1974743A1 (en) 2008-10-01
RU2009139660A (ru) 2011-05-10
PL2131859T3 (pl) 2016-12-30
US20100119488A1 (en) 2010-05-13
EP2129242A1 (en) 2009-12-09

Similar Documents

Publication Publication Date Title
UA97663C2 (ru) Применение bifidobacterium lactis cncm i-3446 для улучшения кишечной микробиоты у детей, родившихся путем кесарева сечения
MY158816A (en) Probiotics for reduction of risk of obesity
MY159072A (en) Probiotics to increase iga secretion in infants born by caesarean section
MY150657A (en) Reduction of risk of diarrhoea
PH12014501749A1 (en) A nutritional composition comprising probiotics and improving sleep patterns
UA100551C2 (en) Synbiotic mixture
MY159076A (en) Use of oligosaccharides containing n-acetyllactosamine for maturation of immune responses in neonates
MY196432A (en) Methods Of Using Human Milk Oligosaccharides For Improving Airway Respiratory Health
MY189329A (en) Mixture of non-digestible oligosaccharides for stimulating the immune system
MX2009012255A (es) Probioticos en ambiente pre y/o postquirurgico.
UA100985C2 (ru) Композиция для питания с нежизнеспособной бифидобактерией и неусваиваемым олигосахаридом
MY169326A (en) Human milk oligosaccharides for preventing injury and/or promoting healing of the gastrointestinal tract
MY148872A (en) Use of bifidobacterium longum for the prevention and treatment of inflammation
NZ601141A (en) Nutritional formulas containing synbiotics
MX356184B (es) Fórmulación pediátrica sintética que comprende un probiótico.
IN2012DN00878A (ru)
IL220613B (en) Use of antibiotics and a probiotic formulation in the preparation of a drug for the treatment of inflammatory bowel disease
UA115520C2 (uk) Дієтична або фармацевтична композиція на основі лактобацил для вагінального або перорального введення
JP2009539371A5 (ru)
PH12017502182A1 (en) Nutritional compositions and infant formulas comprising bifidobacterium animalis ssp. lactis and optionally a mix of oligosaccharides for inducing a gut microbiota close to the one of breast fed infants
IN2012DN06309A (ru)
WO2009080800A3 (en) Method for decreasing abdominal girth by administering a bifidobacterium bacteria
ATE536102T1 (de) Probiotischer stamm von lactobacillus delbrueckii subsp bulgaricus
TH117336B (th) โพรไบโอติกสำหรับลดความเสี่ยงต่อโรคอ้วน
UA52520U (ru) Способ лечения нарушений функционального состояния кишечника у новорожденных и детей младенческого возраста